RocketDNA Ltd. (ASX:RKT)

RocketDNA Statistics

Total Valuation

RocketDNA has a market cap or net worth of AUD 14.65 million. The enterprise value is 14.29 million.

Market Cap	14.65M
Enterprise Value	14.29M

Important Dates

The next estimated earnings date is Wednesday, November 26, 2025.

Earnings Date	Nov 26, 2025
Ex-Dividend Date	n/a

Share Statistics

RocketDNA has 915.52 million shares outstanding. The number of shares has increased by 36.65% in one year.

Current Share Class	915.52M
Shares Outstanding	915.52M
Shares Change (YoY)	+36.65%
Shares Change (QoQ)	+28.18%
Owned by Insiders (%)	18.59%
Owned by Institutions (%)	26.84%
Float	620.05M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.07
PB Ratio	2.94
P/TBV Ratio	3.79
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-6.17
EV / Sales	2.01
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-5.10

Financial Position

The company has a current ratio of 2.16, with a Debt / Equity ratio of 0.34.

Current Ratio	2.16
Quick Ratio	1.91
Debt / Equity	0.34
Debt / EBITDA	n/a
Debt / FCF	-0.61
Interest Coverage	-9.53

Financial Efficiency

Return on equity (ROE) is -52.12% and return on invested capital (ROIC) is -22.17%.

Return on Equity (ROE)	-52.12%
Return on Assets (ROA)	-17.96%
Return on Invested Capital (ROIC)	-22.17%
Return on Capital Employed (ROCE)	-32.70%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	1.00
Inventory Turnover	9.64

Taxes

In the past 12 months, RocketDNA has paid 105,542 in taxes.

Income Tax	105,542
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +0.00% in the last 52 weeks. The beta is 0.32, so RocketDNA's price volatility has been lower than the market average.

Beta (5Y)	0.32
52-Week Price Change	+0.00%
50-Day Moving Average	0.01
200-Day Moving Average	0.01
Relative Strength Index (RSI)	61.03
Average Volume (20 Days)	1,976,990

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, RocketDNA had revenue of AUD 7.09 million and -2.32 million in losses. Loss per share was -0.00.

Revenue	7.09M
Gross Profit	3.40M
Operating Income	-2.04M
Pretax Income	-2.19M
Net Income	-2.32M
EBITDA	-1.25M
EBIT	-2.04M
Loss Per Share	-0.00

Balance Sheet

The company has 1.78 million in cash and 1.70 million in debt, giving a net cash position of 75,609 or 0.00 per share.

Cash & Cash Equivalents	1.78M
Total Debt	1.70M
Net Cash	75,609
Net Cash Per Share	0.00
Equity (Book Value)	4.98M
Book Value Per Share	0.01
Working Capital	2.16M

Cash Flow

In the last 12 months, operating cash flow was -1.05 million and capital expenditures -1.75 million, giving a free cash flow of -2.80 million.

Operating Cash Flow	-1.05M
Capital Expenditures	-1.75M
Free Cash Flow	-2.80M
FCF Per Share	-0.00

Margins

Gross margin is 47.90%, with operating and profit margins of -28.80% and -32.67%.

Gross Margin	47.90%
Operating Margin	-28.80%
Pretax Margin	-30.90%
Profit Margin	-32.67%
EBITDA Margin	-17.59%
EBIT Margin	-28.80%
FCF Margin	n/a

Dividends & Yields

RocketDNA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-36.65%
Shareholder Yield	-36.65%
Earnings Yield	-15.82%
FCF Yield	-19.14%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

RocketDNA has an Altman Z-Score of 0.16 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.16
Piotroski F-Score	2